does retatrutide pop up on drug test Promises Big Weight Loss, but Safety Remains a Question Retatrutide, an experimental weight-loss drug,

Subcutaneous injection delivers the peptide directly into systemic circulation, bypassing first-pass metabolism

As healthcare providers consider these medications for their patients, they must weigh the benefits against potential side effects, such as gastrointestinal discomfort, which can occur with incretin-based therapies

Jump to: GLP-1s for type 2 diabetes | GLP-1s for weight loss | Side effects and safety | Take home message GLP-1 receptor agonists (GLP-1s) are a class of medications approved for individuals living with type 2 diabetes and obesity to help lower blood glucose levels (blood sugar) and support weight loss

doi: 10.1001/jamaophthalmol.2025.6262